Healthy Clinical Trial
Official title:
Cry Management and Awareness Tool (Cool): A Proof of Concept Study to Investigate the Use and Relevance of a Digital Platform for Infant Crying and Fussing
Primary: The rating by the primary caregivers on the use and relevance of data provided by
the Language ENvironment Analysis (LENA) recorder and their level of engagement due to the
content on the Cool mobile app.
Secondary: The rating by the Healthcare Professionals (HCPs) on the use and relevance of data
provided by the LENA recorder in their general practice
Exploratory
- Total crying and fussing time captured by the LENA recorder
- Crying and fussing time perceived by the parents
- Vital parameters like heart rate, sleep recorded by the Fitbit used by the primary
caregiver during crying and fussing events registered by LENA
- Comments and feedback provided by the primary caregiver on the LENA recorder and the
Cool mobile app
- Comments and feedback provided by the HCP on the LENA recorder and the data provided.
- Sleep time recorded by the Cocoon Cam
- Crying time recorded by the Cocoon Cam
- Crying start and end time recorded by the primary caregiver in the COOL app
- Sleep start and end time recorded by the primary caregiver in the COOL app
- Comments and feedback provided by the primary caregiver and HCP on the Cocoon Cam and
the activity log for infant cry and sleep including push notifications in the Cocoon Cam
app
- Usage data from the Cocoon Cam app
At screening visit, after parent(s)/guardian(s) of potential subjects and/or legal
representatives have been informed about the study, they will be requested to sign the
informed consent form (ICF) prior to start of the study. After successful signing of the
informed consent, the investigator will assess the eligibility of the subjects. If the
subject meets all the inclusion and none of the exclusion criteria, the primary caregiver
will complete a detailed questionnaire on subject's demographics, birth, family, feeding
characteristics and primary caregiver's characteristics. The primary caregiver will be
provided the LENA recorder kit and in case consented for Fitbit, they will be provided with
the Fitbit. The primary caregiver will need to complete a training period in order to verify
subject's primary caregiver's ability to properly connect, operate and upload data using the
LENA recorders and uploader. As part of the training period, the primary caregiver will do
1-2 hours of recording using the LENA recorder and successfully upload the data into the LENA
cloud server through the internet. Once the study coordinator verifies that the upload is
successful, the training and feasibility assessment will be considered as complete and the
subject will be considered as enrolled. The primary caregiver of the enrolled subject will be
provided access to the COOL mobile app and the recording period will start.
During the recording period, the subject will be using the LENA recorder and will complete a
daily questionnaire at the end of each day. At the end of 7 days, the site will perform a
phone call and the LENA cry and fuss clock generated from the LENA recorder data for the
recorded period will be shared with the primary caregiver through the COOL mobile app. After
viewing the cry and fuss clock, the primary caregiver will need to complete a questionnaire
on the use of LENA recorder and the content of the COOL mobile app. The primary caregiver
will continue using the LENA recorder for the next 7 days. At the end of 14 days, the LENA
cry and fuss data for the recorded period will be shared with the primary caregiver and the
primary caregiver will need to complete another questionnaire on the use and relevance of the
cry and fuss clock and overall relevance of the COOL mobile app. At the end of the recording
period, the primary caregiver will schedule an appointment with the PI. If the primary
caregiver consents for the use of Fitbit, they will be provided Fitbit to record their vital
parameters like heartrate and sleep pattern through the 14 days after enrolment. At the end
of study visit, the primary caregiver will discuss the data provided by the LENA recorder and
the COOL mobile app with the PI and PI will use the data to explain to the primary care giver
if there is any specific cry pattern that could be assessed based on the objective data from
LENA. The Primary caregiver and PI will complete a questionnaire each on the use of the data
provided by the LENA recorder during their discussion.
For up to 5 subjects in the study, if the primary caregiver consents for the use of Cocoon
Cam they will be provided with the Cocoon Cam kit at screening visit. The primary caregiver
will need to complete a training period to verify the ability to properly connect, operate
and upload data using the LENA recorders and uploader as well as the Cocoon Cam. As part of
the training period, the primary caregiver will have to I) perform 1-2 hours of recording
using the LENA recorder II) successfully upload the data into the LENA cloud server through
the internet, III) use the Cocoon Cam for 1 day, and IV) be able to start using the Cocoon
Cam application. Once the study coordinator verifies that the LENA upload is successful and
Cocoon Cam set-up is complete, the training and feasibility assessment will be considered as
complete and the subject will be considered as enrolled. The primary caregiver of the
enrolled subject will be provided access to the COOL mobile app and the recording period will
start. During the recording period, in addition to the daily questionnaire, the primary
caregiver need to enter cry and sleep time using the COOL app. At the end of 7th day and 14th
day, the primary caregiver need to complete questionnaires on the usability of the Cocoon
Cam.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |